Pharmaceutical composition containing ezrin mutated on tyrosine 353
US6399584B1 · kind B1 · utility
1Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 18, 1998 |
| Grant date | Jun 4, 2002 |
| Priority date | — |
| Expiry date | Mar 18, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a pharmaceutical composition containing an effective amount of ezrin mutated on tyrosine 353, or a functional fragment or derivative thereof, in association with a pharmaceutically acceptable carrier, for use preferably in the prevention and/or treatment of tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.